Aytu BioPharma Inc. Common Stock (AYTU)

About AYTU

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

82

Website

aytubio.com/

Fundamentals

1-day range

$2.25$2.28

Market cap

$24.15M

P/E (trailing)

—

P/E (forward)

-30.13

EPS (trailing)

$-4.41

Dividend yield

—

Beta

0.14

Avg. volume

28.8K

Dividend pay date

December 9, 2020

Forecasts

3 analyst ratings

Aytu BioPharma Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• AYTU

  Aytu BioPharma Inc. Common Stock

  $2.27

  ▲ 1.34%
  Market cap $24.15MP/E —
  $1.65$3.07
• BRNS

  Barinthus Biotherapeutics plc American Depositary Shares

  $0.7464

  ▲ 2.11%
  Market cap $24.51MP/E —
  $0.512$1.83
• TVRD

  Tvardi Therapeutics Inc. Common Stock

  $1.8

  ▲ 0.00%
  Market cap $25.13MP/E —
  $1.5$43.65
• CALC

  CalciMedica Inc. Common Stock

  $0.4644

  ▼ 1.19%
  Market cap $23.14MP/E —
  $0.4606$7.2
• LGVN

  Longeveron Inc. Class A Common Stock

  $6.72

  ▼ 1.47%
  Market cap $23.13MP/E —
  $4.75$12.3
• ACTU

  Actuate Therapeutics Inc. Common stock

  $1.67

  ▼ 1.18%
  Market cap $25.36MP/E —
  $0.9$9.22
• BTAI

  BioXcel Therapeutics Inc. Common Stock

  $0.1824

  ▼ 74.63%
  Market cap $26.17MP/E —
  $0.1569$4.29

P/E shows — for peers not currently carrying a live signal of their own.

• Joshua R. Disbrow · July 28, 2026 · Grant

  30.0K
• Greg Pyszczymuka · July 28, 2026 · Grant

  20.0K
• Jarrett Disbrow · July 28, 2026 · Grant

  15.0K
• Ryan J. Selhorn · July 28, 2026 · Grant

  25.0K
• Abhinav Jain · July 28, 2026 · Grant

  10.0K
• Carl Dockery · July 28, 2026 · Grant

  10.0K
• John Donofrio Jr. · July 28, 2026 · Grant

  10.0K
• Vivian H. Liu · July 28, 2026 · Grant

  10.0K

Institutional Ownership

March 31, 2026

Total shares held

3.86M

Total value held

$10.10M

Institutional holders

34